Travere Therapeutics, Inc.
$49.60
-3.19 (-6.04%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -23.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -26.5%
Own TVTX?
See how TVTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.